Stockholm3 – a blood test that combines protein markers, genetic markers and clinical data with an advanced algorithm in order to detect aggressive prostate cancer at an early stage. Read more.

Are you interested in scientific collaborations, please contact us on sthlm3@ki.se

Stockholm3 is being available for clinical use by KI spin-out company A3P Biomedical.